Mutations in the gene for peripheral myelin protein 22 (PMP22) are associated with peripheral neuropathy in mice and humans. PMP22 is produced mainly in Schwann cells in the peripheral nervous system where it is localised to compact myelin. The function of PMP22 is unclear but its low abundance makes it unlikely to be a structural myelin protein. I have studied the peripheral nerves of two different mouse models with alterations in the pmp22 gene. (1) The Trembler-J (Tr^J) mouse which has a point mutation [L16P] in the first transmembrane domain of PMP22. (2) PMPP22 overexpressing transgenic mice which have 7 (C22), 4 (C61) and 2 (C2) copies of the human PMP22 gene in addition to the mouse pmp22 gene. In the nerves of adult Tr^J mice there was considerable evidence of abnormal Schwann cell-axon interactions. Abnormal features were reproduced in the early stages of regeneration following crush injury. This demonstrates that the abnormalities are a result of an intrinsic abnormality of Tr^J Schwann cells and not secondary changes related to demyelination. In the initial stages of postnatal development the number of axons that were singly ensheathed was the same in all the mutants examined, indicating that PMP22 does not function in the initial enclosure of groups of axons and subsequent separation of single axons. All strains examined had an increased proportion of fibres that were incompletely surrounded by Schwann cell cytoplasm indicating that this step is disrupted in PMP22 mutants. Increasing the number of copies of PMP22 resulted in an increasing severity of phenotype. In C22 (7 copy) animals myelin formation was delayed or non-existent in many fibres whereas in C61 animals myelination initially appeared normal with abnormality appearing later in a small population of fibres. The C2 strain appeared relatively unaffected. It is concluded that PMP22 functions in the initiation of myelination and most probably involves the ensheathment of the axon by the Schwann cell, and the extension of this cell along the axon. Abnormalities are most likely to result from defective interactions between the axon and the Schwann cell.

No description available.

The objective of my thesis is to explore the use of the conducting polymer, polypyrrole, in neural applications. In addition a supplementary aspect of dissertation will involves understanding the effects of external stimuli on nervous system cells, with the ultimate goal of designing therapeutic systems for nerve regeneration. In normal development and peripheral nervous system repair, nerves encounter naturally occurring chemical, physical, and electrical stimuli. Polypyrrole (PPy) has attracted much attention for use in numerous biomedical applications as it presents chemical, physical and electrical stimuli. In addition, PPy is particularly exciting because the extent by which chemical, physical, and electrical cues are presented to the injured nerve can be easily tailored. Thus, conducting polymers are excellent scaffolds for the exploration of how the cellular components of the nervous system (i.e., Schwann cells and neurons) interact with chemical, topographical, and electrical stimuli. This dissertation covers three main objectives and is supplemented by two additional topics. The two additional topics explore the effect stimuli present on the conducting polymer PPy have on neural interfaces. These fundamental studies use computational modeling to gain a better understanding of cellular motility on substrates containing different stimuli. Both topics are covered in the appendices of this dissertation. With regards to the three main objectives, I first characterized and optimized the electrochemical synthesis of the conducting polymer, PPy, for Schwann cell biocompatibility. Next, I investigated the effect the application of electrical cues through PPy has on Schwann cell migration. In addition to investigating the effect of the direct electrical current on Schwann cells I also considered the effect that electrical stimulation provided by PPy has on protein adsorption. Finally, I developed a hybrid PPy material that will provide advantageous properties for neural interfaces. Specifically, I describe the development of a polypyrrole:poly-(lactic-co-glycolic) acid blend for neural applications. In summary the three specific objectives covered in my thesis are: Specific Aim 1: Characterize and optimize the electrochemical synthesis of the conducting polymer, polypyrrole, for Schwann cell biocompatibility Specific Aim 2: Determine the effect of electrical stimulation on Schwann cell migration Specific Aim 3: Develop polypyrrole:poly-(lactic-co-glyolic) acid blends for neural engineering applications. / text

Fas Ligand (FasL) binds to the Fas receptor to induce apoptosis or activate other signaling pathways. FasL can also transduce "reverse signals" and thus participate in bidirectional signaling. The FasL intracellular domain contains consensus sequences for phosphorylation and a proline rich protein interaction domain. This latter region of FasL has previously been implicated in FasL reverse signaling and regulation of FasL surface expression. In this report, we sought to identify novel FasL interacting proteins to help understand signaling through and trafficking of this death factor. Using mass spectrometry, we identified sorting nexin 18, adaptin beta, Grb2, PACSIN2 and PACSIN3 as FasL interacting proteins. RNAi mediated knockdown of Grb2 significantly reduced the surface expression of FasL and increased its expression intracellularly. Our data show that Grb2 controls the subcellular localization of FasL. All other proteins identified in our screen could be classified as trafficking-associated proteins, highlighting the complex regulation of the surface expression of this death factor.

No description available.

The childhood neuromuscular disease spinal muscular atrophy (SMA) is caused by low levels of survival motor neuron (SMN) protein. Historically, SMA has been characterised as a disease primarily affecting lower motor neurons. However, recent breakthroughs have revealed defects in other non-neuronal cells and tissues. In vivo analysis of peripheral nerve showed defects in Schwann cells, manifesting as abnormal myelination and delayed maturation of axo-glia interactions. The experiments in this thesis were designed to build on these observations and examine whether Schwann cell defects are intrinsic and occur as a primary result of low levels of SMN in that cell type, or rather represent a secondary consequence of pathology in neighbouring motor neurons. I initially developed a protocol to allow isolation of high-yields of purified, myelination-competent Schwann cells from ‘Taiwanese’ SMA mice. SMA-derived Schwann cells had significantly reduced SMN levels and failed to respond normally to differentiation cues. Increasing SMN levels restored myelin protein expression in Schwann cells from SMA mice. Perturbations in expression of key myelin proteins were likely due to failure of protein translation and/or stability rather than transcriptional defects. Co-cultures of healthy neurons with SMA Schwann cells revealed a significant reduction in myelination compared to cultures where wild-type Schwann cells were used. The presence of SMA Schwann cells also disrupted neurite stability. Perturbations in the expression of key extracellular matrix proteins, such as laminin α2, in SMA-derived Schwann cells suggests that Schwann cells were influencing neurite stability by modulating the composition of the extracellular matrix. Previous studies have demonstrated that low levels of SMN lead to disruption of ubiquitin homeostasis and decreased expression of ubiquitin-like modifier activating enzyme (UBA1) in the neuromuscular system, driving neuromuscular pathology via a beta-catenin dependent pathway. Label-free proteomics analysis of SMA and control Schwann cells identified 195 proteins with modified expression profiles. Bioinformatic analysis of these proteins using Ingenuity Pathway Analysis (IPA) software confirmed that major disruption of protein ubiquitination pathways was also present in Schwann cells from SMA mice. Immunolabeling and proteomics data both revealed that UBA1 levels were significantly reduced in SMA-derived Schwann cells. However, loss of UBA1 in Schwann cells did not lead to downstream modifications in beta-catenin pathways. Pharmacological inhibition of UBA1 in healthy Schwann cells was sufficient to induce defects in myelin protein expression, suggesting that UBA1 defects contribute directly to Schwann cell disruption in SMA. I conclude that low levels of SMN induce intrinsic defects in Schwann cells, mediated at least in part through disruption to ubiquitination pathways.

Orientador: Vânia Nieto Brito de Souza / Resumo: A infecção por Mycobacterium leprae (M. leprae) desencadeia alterações no status funcional das células de Schwann (SCs), responsáveis pela produção da bainha de mielina e homeostasia neural. Estudos prévios indicam que lesões nos nervos periféricos modulam a expressão de fatores-chave envolvidos na diferenciação e maturação das SCs. Na hanseníase, alterações funcionais nessas células podem estar envolvidas na patogênese do dano neural. O presente estudo buscou determinar a expressão dos fatores de transcrição KROX-20, SOX-10, JUN e do receptor p75NTR, envolvidos nos processos de diferenciação e maturação de SCs. Os dados foram obtidos a partir de cultura primária de SCs murinas expostas ao M. leprae durante sete e 14 dias, com diferentes multiplicidades de infecção (MOI 100:1, MOI 50:1). Os mesmos fatores foram avaliados in vivo, em nervos ciáticos de camundongos nude (NUFoxn1nu), após seis e nove meses de infecção. Comparando-se grupos experimentais em relação aos controles, nossos resultados em cultura de SCs demonstram redução significativa de KROX-20 e SOX-10, bem como elevação na frequência de células imunomarcadas por p75NTR. Paralelamente, nervos ciáticos de camundongos nude infectados por M. leprae apresentaram queda de KROX-20 e aumento de p75NTR, quando comparados aos animais não infectados. Em conjunto, nossos resultados corroboram achados prévios sobre a interferência de M. leprae na expressão de fatores-chave envolvidos na maturação celular, favorecendo a manuten... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Mycobacterium leprae infection (M. leprae) triggers changes in the functional status of Schwann cells (SCs), which are responsible for the production of myelin sheath and neural homeostasis. Previous studies indicate that peripheral nerve injury modulates the expression of key factors involved in the differentiation and maturation of SCs. In leprosy, functional changes in these cells may be involved in the pathogenesis of neural damage. The present study sought to determine the expression of the transcription factors KROX-20, SOX-10, JUN and the neurotrophic receptor p75NTR, involved in the differentiation and maturation processes of SCs. Data were obtained from primary murine SCs culture exposed to M. leprae for seven and 14 days, with different multiplicities of infection (MOI 100:1, MOI 50:1). The same factors were evaluated in vivo on sciatic nerve of nude mice (NU-Foxn1nu), after six and nine months of infection. By comparing experimental groups versus controls, our SC culture results demonstrate significant reduction of KROX-20 and SOX-10, as well as elevation in the frequency of cells immunolabelled by p75NTR. In parallel, sciatic nerves of nude mice infected with M. leprae showed a decrease in KROX-20 and an increase of p75NTR when compared to uninfected animals. Our results corroborate previous findings on M. leprae interference in the expression of key factors involved in cell maturation, favoring the maintenance of a non-myelinating phenotype in SCs, with possible ... (Complete abstract click electronic access below) / Mestre

Schwann cells are the glial cells of the peripheral nervous system. When transplanted into the injured central or peripheral nervous systems they promote repair. Traditionally Schwann cells have been isolated from the sciatic nerve, creating nerve-SC. An alternative Schwann cell source is from the differentiation of skin-derived precursors (SKPs), stem cells found in the skin, to Schwann cells (SKP-SC). SKP-SC have shown enhanced regenerative ability compared to nerve-SC. This study compares nerve-SC with SKP-SC at the functional and gene expression level to determine their degree of similarity and find their sources of variance. The functional ability of both Schwann cell types appeared similar. Their gene expression, as assessed by microarray, was similar but not identical. Genes that differed between nerve-SC and SKP-SC may represent differences important to regeneration. The similarity of SKP-SC to nerve-SC supports the use of SKP-SC for repair, and reasons for enhanced regeneration by SKP-SC are suggested.

Schwann cells are the glial cells of the peripheral nervous system. When transplanted into the injured central or peripheral nervous systems they promote repair. Traditionally Schwann cells have been isolated from the sciatic nerve, creating nerve-SC. An alternative Schwann cell source is from the differentiation of skin-derived precursors (SKPs), stem cells found in the skin, to Schwann cells (SKP-SC). SKP-SC have shown enhanced regenerative ability compared to nerve-SC. This study compares nerve-SC with SKP-SC at the functional and gene expression level to determine their degree of similarity and find their sources of variance. The functional ability of both Schwann cell types appeared similar. Their gene expression, as assessed by microarray, was similar but not identical. Genes that differed between nerve-SC and SKP-SC may represent differences important to regeneration. The similarity of SKP-SC to nerve-SC supports the use of SKP-SC for repair, and reasons for enhanced regeneration by SKP-SC are suggested.

Current treatments for spinal cord injury (SCI) are extremely limited due to the fact that the central nervous system lacks the intrinsic ability to regenerate, and constitutes a poor environment for regenerative axon growth. Nerve tissue engineering is an emerging field with the aim of repairing or creating new nerve tissues to promote functional recovery by using artificial tissue repair scaffolds. The design of a stable and consistent animal model of SCI is essential to study the effectiveness of scaffolds in promoting nervous system repair. In this study, a partial transection animal model was created with a three dimensional lesion at T8-T9 that disrupts axonal pathways unilaterally in the dorsal columns of the rat spinal cord. Alginate hydrogel scaffolds incorporating living Schwann cells were fabricated to evaluate the abilities of those scaffolds to foster axonal regeneration. The surgical technique was improved to provide better outcomes related to bleeding during surgery, weight control, neurological function and surgery duration. The survival rate of animals during the surgical procedure and post-surgery period was ultimately increased to 100%. Histology and immunohistochemistry results indicated that implanted alginate scaffolds may induce larger cavities and extenuate harmful inflammation responses, but that effect was ameliorated by inclusion of Schwann cells in the scaffold. However, neither plain alginate scaffolds nor scaffolds containing living Schwann cells were able to improve regeneration of identified axon tracts in the spinal dorsal columns. This research also employed a synchrotron based x-ray phase contrast imaging technique coupled with computed-tomography to visualize the low optical density structural features of scaffolds and spinal cord tissues in formaldehyde fixed specimens. The imaging results suggest that this is a promising method for analyzing the structure of tissue repair scaffolds within the spinal cord. This degree of structural characterization, potentially applicable to living tissue, is not afforded by other conventional image analysis techniques.